Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity.
Ercole Brusamolino(University of Pavia), Mario Lazzarino, Cristiana Pascutto(University of Pavia), Enrica Morra(University of Bologna), Livio Gargantini, Luigi Rigacci(Azienda Ospedaliero-Universitaria Careggi), G. Pagnucco, Sergio Fava, Graziella Pinotti(Medica (Italy)), Lilj Uziel, Chiara Rusconi(Fondazione IRCCS Istituto Nazionale dei Tumori), L Montalbetti
PubMed
April 1, 2006
Cited by 114
Related Papers
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
ALK+ lymphoma: clinico-pathological findings and outcome.
|PubMed|1999|569